S

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990

Watchlist Manager
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Watchlist
Price: 178 HKD 3.43% Market Closed
Market Cap: 38.4B HKD
Have any thoughts about
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd?
Write Note

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Other

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Other Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other CAGR 3Y CAGR 5Y CAGR 10Y
S
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
HKEX:6990
Other
-ÂĄ10m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Other
ÂĄ172.1m
CAGR 3-Years
-82%
CAGR 5-Years
-56%
CAGR 10-Years
N/A
Akeso Inc
HKEX:9926
Other
-ÂĄ126m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other
-ÂĄ23.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Other
-ÂĄ967.1m
CAGR 3-Years
-37%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other
-ÂĄ313.6m
CAGR 3-Years
N/A
CAGR 5-Years
-31%
CAGR 10-Years
N/A
No Stocks Found

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Glance View

Market Cap
39.7B HKD
Industry
Biotechnology

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Chengdu, Sichuan and currently employs 1,155 full-time employees. The company went IPO on 2023-07-11. Sichuan Kelun-Biotech Biopharmaceutical Co Ltd, formerly Sichuan Kelun Biotech Biopharmaceutical Co Ltd, is a China-based company mainly engaged in the research and development, production, and sales of drugs. The firm is mainly engaged in the research and development, production, and sales of biopharmaceuticals, chemical raw materials, and chemical drug formulations. The firm's products are mainly used for the treatment of breast cancer, non-small cell lung cancer, Gastrointestinal cancer and other non tumor diseases.

Intrinsic Value
144.1 HKD
Overvaluation 19%
Intrinsic Value
Price
S

See Also

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Other?
Other
-10m CNY

Based on the financial report for Dec 31, 2023, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Other amounts to -10m CNY.

What is Sichuan Kelun-Biotech Biopharmaceutical Co Ltd's Other growth rate?
Other CAGR 1Y
-242%

Over the last year, the Other growth was -242%.

Back to Top